| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 4.13e-10 | 26 | 31 | 5 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 8.91e-10 | 30 | 31 | 5 | GO:0018455 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 4.94e-08 | 24 | 31 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | ethanol binding | 6.75e-08 | 6 | 31 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.43e-06 | 127 | 31 | 5 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.16e-06 | 138 | 31 | 5 | GO:0016614 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 1.63e-05 | 766 | 31 | 8 | GO:0016491 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.81e-05 | 891 | 31 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | NAD binding | 1.96e-04 | 73 | 31 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 3.55e-04 | 1189 | 31 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | alcohol binding | 5.24e-04 | 102 | 31 | 3 | GO:0043178 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 2.78e-09 | 3 | 30 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 8.54e-09 | 17 | 30 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.10e-08 | 18 | 30 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 2.77e-08 | 5 | 30 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 3.16e-08 | 23 | 30 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.75e-07 | 89 | 30 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 2.30e-07 | 94 | 30 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 3.20e-07 | 40 | 30 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 4.00e-07 | 105 | 30 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 4.19e-07 | 106 | 30 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 6.21e-07 | 47 | 30 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 1.01e-06 | 53 | 30 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 1.86e-06 | 17 | 30 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 1.92e-06 | 144 | 30 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 3.69e-06 | 73 | 30 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 1.06e-05 | 95 | 30 | 4 | GO:0006081 | |
| GeneOntologyBiologicalProcess | aldehyde biosynthetic process | 1.21e-05 | 31 | 30 | 3 | GO:0046184 | |
| GeneOntologyBiologicalProcess | response to testosterone | 6.19e-05 | 53 | 30 | 3 | GO:0033574 | |
| GeneOntologyBiologicalProcess | response to ethanol | 8.37e-05 | 161 | 30 | 4 | GO:0045471 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 1.29e-04 | 180 | 30 | 4 | GO:0120254 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 2.93e-04 | 412 | 30 | 5 | GO:0006066 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 3.24e-04 | 421 | 30 | 5 | GO:0044282 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 5.56e-04 | 731 | 30 | 6 | GO:0032787 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 5.78e-04 | 1035 | 30 | 7 | GO:0019752 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 6.59e-04 | 1058 | 30 | 7 | GO:0043436 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 6.82e-04 | 1064 | 30 | 7 | GO:0006082 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 7.47e-04 | 286 | 30 | 4 | GO:0042445 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 8.97e-04 | 131 | 30 | 3 | GO:0032526 | |
| GeneOntologyBiologicalProcess | response to alcohol | 1.03e-03 | 312 | 30 | 4 | GO:0097305 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 2.13e-03 | 641 | 30 | 5 | GO:1901615 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 2.83e-03 | 684 | 30 | 5 | GO:0010817 | |
| MousePheno | abnormal ethanol metabolism | 1.01e-07 | 6 | 25 | 3 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 1.76e-07 | 7 | 25 | 3 | MP:0005444 | |
| MousePheno | abnormal vitamin or vitamin cofactor metabolism | 2.27e-06 | 15 | 25 | 3 | MP:0013274 | |
| MousePheno | abnormal vitamin A metabolism | 2.27e-06 | 15 | 25 | 3 | MP:0011233 | |
| MousePheno | abnormal vitamin metabolism | 2.27e-06 | 15 | 25 | 3 | MP:0013244 | |
| MousePheno | enhanced behavioral response to alcohol | 2.79e-06 | 16 | 25 | 3 | MP:0009751 | |
| MousePheno | abnormal behavioral response to alcohol | 9.98e-06 | 24 | 25 | 3 | MP:0020157 | |
| MousePheno | enhanced behavioral response to addictive substance | 6.38e-05 | 44 | 25 | 3 | MP:0009749 | |
| MousePheno | weight loss | 1.97e-04 | 312 | 25 | 5 | MP:0001263 | |
| MousePheno | enhanced behavioral response to xenobiotic | 2.45e-04 | 69 | 25 | 3 | MP:0009746 | |
| MousePheno | abnormal behavioral response to addictive substance | 7.72e-04 | 102 | 25 | 3 | MP:0009748 | |
| Domain | ADH_N | 7.98e-14 | 16 | 30 | 6 | IPR013154 | |
| Domain | ADH_N | 7.98e-14 | 16 | 30 | 6 | PF08240 | |
| Domain | - | 1.85e-13 | 18 | 30 | 6 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 2.70e-13 | 19 | 30 | 6 | PF00107 | |
| Domain | ADH_SF_Zn-type | 2.70e-13 | 19 | 30 | 6 | IPR002085 | |
| Domain | ADH_C | 2.70e-13 | 19 | 30 | 6 | IPR013149 | |
| Domain | ADH_Zn_CS | 4.20e-13 | 8 | 30 | 5 | IPR002328 | |
| Domain | ADH_ZINC | 4.20e-13 | 8 | 30 | 5 | PS00059 | |
| Domain | GroES-like | 1.33e-12 | 24 | 30 | 6 | IPR011032 | |
| Domain | PKS_ER | 3.25e-11 | 16 | 30 | 5 | IPR020843 | |
| Domain | PKS_ER | 3.25e-11 | 16 | 30 | 5 | SM00829 | |
| Domain | - | 2.49e-07 | 169 | 30 | 6 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 2.86e-07 | 173 | 30 | 6 | IPR016040 | |
| Domain | WD40_repeat_CS | 2.27e-03 | 164 | 30 | 3 | IPR019775 | |
| Domain | WD40 | 8.12e-03 | 259 | 30 | 3 | PF00400 | |
| Domain | WD40 | 8.91e-03 | 268 | 30 | 3 | SM00320 | |
| Domain | WD40_repeat | 9.28e-03 | 272 | 30 | 3 | IPR001680 | |
| Domain | WD_REPEATS_1 | 9.84e-03 | 278 | 30 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 9.94e-03 | 279 | 30 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 9.94e-03 | 279 | 30 | 3 | PS50294 | |
| Domain | WD40_repeat_dom | 1.18e-02 | 297 | 30 | 3 | IPR017986 | |
| Domain | - | 1.60e-02 | 333 | 30 | 3 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.62e-02 | 335 | 30 | 3 | IPR015943 | |
| Domain | PDZ | 2.14e-02 | 141 | 30 | 2 | PF00595 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.98e-12 | 12 | 19 | 5 | M14663 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 7.73e-10 | 11 | 19 | 4 | MM15405 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 2.07e-09 | 42 | 19 | 5 | M699 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 2.07e-09 | 42 | 19 | 5 | M16743 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 3.19e-09 | 15 | 19 | 4 | M39717 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 1.55e-08 | 62 | 19 | 5 | M11521 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.82e-08 | 64 | 19 | 5 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.88e-08 | 70 | 19 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.32e-08 | 72 | 19 | 5 | M9257 | |
| Pathway | REACTOME_ABACAVIR_ADME | 1.16e-07 | 8 | 19 | 3 | MM14869 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.12e-07 | 104 | 19 | 5 | M738 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 2.48e-07 | 10 | 19 | 3 | MM15833 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 6.66e-06 | 28 | 19 | 3 | MM15188 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 7.86e-06 | 98 | 19 | 4 | MM15942 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 8.61e-06 | 220 | 19 | 5 | M10320 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 9.11e-06 | 31 | 19 | 3 | M39714 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.03e-05 | 105 | 19 | 4 | MM14842 | |
| Pathway | WP_RETINOL_METABOLISM | 2.65e-05 | 44 | 19 | 3 | MM15851 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 3.68e-05 | 49 | 19 | 3 | MM15186 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.83e-04 | 219 | 19 | 4 | MM14838 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 3.91e-04 | 22 | 19 | 2 | M27445 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 4.09e-04 | 110 | 19 | 3 | MM16642 | |
| Pathway | REACTOME_DRUG_ADME | 5.15e-04 | 119 | 19 | 3 | MM15692 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.50e-03 | 43 | 19 | 2 | M27443 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 2.02e-03 | 191 | 19 | 3 | MM15586 | |
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 2.40e-15 | 6 | 31 | 5 | 17185388 | |
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 2.40e-15 | 6 | 31 | 5 | 16121213 | |
| Pubmed | 8.41e-15 | 7 | 31 | 5 | 16685648 | ||
| Pubmed | 8.41e-15 | 7 | 31 | 5 | 23456092 | ||
| Pubmed | 8.41e-15 | 7 | 31 | 5 | 11784316 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 8.41e-15 | 7 | 31 | 5 | 23468174 | |
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 5.16e-13 | 4 | 31 | 4 | 3996732 | |
| Pubmed | 2.58e-12 | 5 | 31 | 4 | 7738026 | ||
| Pubmed | 2.58e-12 | 5 | 31 | 4 | 8892527 | ||
| Pubmed | 2.58e-12 | 5 | 31 | 4 | 8621625 | ||
| Pubmed | 2.58e-12 | 5 | 31 | 4 | 10358022 | ||
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 7.73e-12 | 6 | 31 | 4 | 9982 | |
| Pubmed | 7.73e-12 | 6 | 31 | 4 | 12027900 | ||
| Pubmed | 1.80e-11 | 7 | 31 | 4 | 16047160 | ||
| Pubmed | 3.60e-11 | 8 | 31 | 4 | 18331377 | ||
| Pubmed | 2.54e-10 | 12 | 31 | 4 | 12128098 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 6.41e-10 | 3 | 31 | 3 | 9145544 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 3428612 | ||
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 6.41e-10 | 3 | 31 | 3 | 3157987 | |
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 6.41e-10 | 3 | 31 | 3 | 6816803 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 6756216 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 2169444 | ||
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 6.41e-10 | 3 | 31 | 3 | 10424757 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 11960985 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 2474823 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 6.41e-10 | 3 | 31 | 3 | 7748347 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 2737681 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 6.41e-10 | 3 | 31 | 3 | 15670660 | |
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 6.41e-10 | 3 | 31 | 3 | 23772048 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 37806378 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 7840644 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 6.41e-10 | 3 | 31 | 3 | 8486690 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 8163197 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 3006456 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 2935875 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 6.41e-10 | 3 | 31 | 3 | 24787690 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 6.41e-10 | 3 | 31 | 3 | 15554233 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 35354963 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 6370228 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 8018987 | ||
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 6.41e-10 | 3 | 31 | 3 | 16801720 | |
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 6.41e-10 | 3 | 31 | 3 | 33586683 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 2347582 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 3011597 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 19618839 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 9733106 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 36224745 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 11893554 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 9202249 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 9002638 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 9241435 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 8813054 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 15193143 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 29663519 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 10880953 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 12631290 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 2893758 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 12851412 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 6.40e-09 | 5 | 31 | 3 | 19193628 | |
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 11836246 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 18996923 | ||
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 6.40e-09 | 5 | 31 | 3 | 22079585 | |
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 7026729 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 1316195 | ||
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 26807981 | ||
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 17257171 | ||
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 518534 | ||
| Pubmed | 1.82e-08 | 32 | 31 | 4 | 17270348 | ||
| Pubmed | Androgen regulation of gene expression in primary epithelial cells of the mouse kidney. | 2.24e-08 | 7 | 31 | 3 | 8119157 | |
| Pubmed | 2.24e-08 | 7 | 31 | 3 | 37953328 | ||
| Pubmed | 3.58e-08 | 8 | 31 | 3 | 2040456 | ||
| Pubmed | 3.58e-08 | 8 | 31 | 3 | 7937138 | ||
| Pubmed | 5.37e-08 | 9 | 31 | 3 | 11747070 | ||
| Pubmed | 5.37e-08 | 9 | 31 | 3 | 93520 | ||
| Pubmed | 1.05e-07 | 11 | 31 | 3 | 2565740 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 1.06e-07 | 130 | 31 | 5 | 19874574 | |
| Pubmed | Differential gene expression in the developing mouse ureter. | 1.40e-07 | 12 | 31 | 3 | 16459152 | |
| Pubmed | Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease. | 2.32e-07 | 14 | 31 | 3 | 26835538 | |
| Pubmed | 2.32e-07 | 14 | 31 | 3 | 2902233 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 2.90e-07 | 15 | 31 | 3 | 9726281 | |
| Pubmed | 3.56e-07 | 16 | 31 | 3 | 15765518 | ||
| Pubmed | Mouse microsatellites from a flow-sorted 4:6 Robertsonian chromosome. | 6.15e-07 | 19 | 31 | 3 | 1450512 | |
| Pubmed | 6.15e-07 | 19 | 31 | 3 | 16705022 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 8201622 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 29390059 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 25503943 | ||
| Pubmed | [Genetic variations in alcohol dehydrogenase, drinking habits and alcoholism]. | 7.69e-07 | 2 | 31 | 2 | 18761854 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 24735490 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 16184481 | ||
| Pubmed | Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes. | 7.69e-07 | 2 | 31 | 2 | 17923853 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 19550411 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 29058369 | ||
| Pubmed | ADH genotype does not modify the effects of alcohol on high-density lipoprotein. | 7.69e-07 | 2 | 31 | 2 | 12658118 | |
| Pubmed | Three-dimensional structures of the three human class I alcohol dehydrogenases. | 7.69e-07 | 2 | 31 | 2 | 11274460 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 17134660 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 16930209 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 20031627 | ||
| Pubmed | Alcohol drinking habits, alcohol dehydrogenase genotypes and risk of acute coronary syndrome. | 7.69e-07 | 2 | 31 | 2 | 20494945 | |
| Interaction | ADH1B interactions | 8.43e-07 | 13 | 30 | 3 | int:ADH1B | |
| Interaction | ADH1A interactions | 2.14e-05 | 5 | 30 | 2 | int:ADH1A | |
| Cytoband | 4q23 | 1.54e-12 | 20 | 31 | 5 | 4q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 4.29e-11 | 37 | 31 | 5 | chr4q23 | |
| Cytoband | 20q11.22 | 2.90e-04 | 37 | 31 | 2 | 20q11.22 | |
| Cytoband | 9p13.3 | 1.19e-03 | 75 | 31 | 2 | 9p13.3 | |
| GeneFamily | Alcohol dehydrogenases | 4.04e-14 | 8 | 19 | 5 | 397 | |
| GeneFamily | WD repeat domain containing | 2.45e-03 | 262 | 19 | 3 | 362 | |
| GeneFamily | PDZ domain containing | 1.09e-02 | 152 | 19 | 2 | 1220 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 1.50e-06 | 310 | 31 | 6 | MM16608 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 8.16e-06 | 109 | 31 | 4 | MM1214 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_UP | 1.44e-05 | 40 | 31 | 3 | M3649 | |
| Coexpression | MCDOWELL_ACUTE_LUNG_INJURY_DN | 3.18e-05 | 52 | 31 | 3 | MM693 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 7.03e-05 | 372 | 31 | 5 | MM1043 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_0HR | 7.44e-05 | 69 | 31 | 3 | MM1024 | |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP | 8.64e-05 | 199 | 31 | 4 | M9502 | |
| Coexpression | GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN | 8.81e-05 | 200 | 31 | 4 | M3222 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_DN | 1.07e-04 | 78 | 31 | 3 | M9911 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 1.12e-04 | 213 | 31 | 4 | M12176 | |
| Coexpression | BROWNE_HCMV_INFECTION_16HR_DN | 1.29e-04 | 83 | 31 | 3 | M19130 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P4 | 2.66e-04 | 106 | 31 | 3 | MM1216 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 7.65e-06 | 183 | 31 | 4 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 8.33e-06 | 187 | 31 | 4 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 198 | 31 | 4 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 200 | 31 | 4 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 200 | 31 | 4 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 200 | 31 | 4 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 200 | 31 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 200 | 31 | 4 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 155 | 31 | 3 | 8742a4eef328c05ca9a88e499868e45073545094 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.91e-04 | 162 | 31 | 3 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.17e-04 | 169 | 31 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 170 | 31 | 3 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 171 | 31 | 3 | 59d79c3e36a4930af42ebc96f05570641b9fb864 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 172 | 31 | 3 | 7e94ff45812f0d03829976339240f3e4ba557122 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 172 | 31 | 3 | 4f4d39d26c40524dbdce39334dddd0eb30c140b2 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.36e-04 | 174 | 31 | 3 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.40e-04 | 175 | 31 | 3 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | 1b077084b78e62ead603f72c9db6ce74a3953f81 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 179 | 31 | 3 | 10baf575f06f9a15384bcdc751446b4670acf942 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-04 | 180 | 31 | 3 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 181 | 31 | 3 | 0a44781cc34535f061812d1370f748b7bbdef17b | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 2.65e-04 | 181 | 31 | 3 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 181 | 31 | 3 | 48d28eafbb5f4b141deeb0bf020dfca39e7be7a5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 185 | 31 | 3 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | P28-Endothelial-unknown_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.87e-04 | 186 | 31 | 3 | dde38decf368775694bbeae38a3ff084017c34ab | |
| ToppCell | P28-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.87e-04 | 186 | 31 | 3 | a38f84f478798951c8798c8e90e4897c729cf630 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.87e-04 | 186 | 31 | 3 | 375642f353842184792a834361284d6897c728de | |
| ToppCell | P15-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.92e-04 | 187 | 31 | 3 | 60f41b1f1b656d211b80398aa2cf0ac0cdad9372 | |
| ToppCell | P15-Endothelial-unknown_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.92e-04 | 187 | 31 | 3 | d543ddc63f864b6d0982c4ff652af174af085c4a | |
| ToppCell | P03-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.92e-04 | 187 | 31 | 3 | 55618ceec367c1c51ed5c447063d7fbd5c7e0808 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 188 | 31 | 3 | 7e27e49ec1eb02fb74c86ec2ccb84751bc778b21 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 188 | 31 | 3 | 4b14c3ad80507245564d5be96d33fd9361f67dd0 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.96e-04 | 188 | 31 | 3 | c0a03e33027f52b5c25ffbc8f822128e5160ed20 | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.01e-04 | 189 | 31 | 3 | f515a04ae1746257d4568cea13a3dd75b4b05275 | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.01e-04 | 189 | 31 | 3 | fcfb28bd96471affc13e55aa7228f594aaa967cd | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.05e-04 | 190 | 31 | 3 | 5d25e40bc2cca314f4265e4001a546e6d99e2a79 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 3.05e-04 | 190 | 31 | 3 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | droplet-Bladder|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 190 | 31 | 3 | 170484f7a6f0a0d0792bbe1bb04abad060b7188e | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.15e-04 | 192 | 31 | 3 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 192 | 31 | 3 | 9a1aeac3ecf31f865a23d8ee15a82aef31779089 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-04 | 192 | 31 | 3 | 5692bd57093852d442400383850f416c497dcc7d | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 192 | 31 | 3 | 53d438e35c14e7656585942b788459e6d843c555 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.15e-04 | 192 | 31 | 3 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-04 | 192 | 31 | 3 | 0b506fb5bca54a50949932293c6f86d974a3acdd | |
| ToppCell | droplet-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-04 | 193 | 31 | 3 | 25129080f8a40b2988a5d9dfec36ff9e72c27e61 | |
| ToppCell | 10x5'-Liver|World / Manually curated celltypes from each tissue | 3.20e-04 | 193 | 31 | 3 | d010d47d763c99e68aede59345392f2a8c77d7ac | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 193 | 31 | 3 | ffdcbc5caff7fd4cc2e83dd21a05d43b0593d542 | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-04 | 193 | 31 | 3 | 3a5ad8ffad441e30a6e1bd017da7720ad57f6c57 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | f35f03412b596b6b570b377ba1a607409d984bb1 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-04 | 194 | 31 | 3 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-04 | 194 | 31 | 3 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-MAIT|Liver / Manually curated celltypes from each tissue | 3.30e-04 | 195 | 31 | 3 | 6da0db2a36a34952daab87d74367b491582dedea | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like|Liver / Manually curated celltypes from each tissue | 3.30e-04 | 195 | 31 | 3 | 37853fe760eac27ecb2fe42ebff42deca0153400 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 195 | 31 | 3 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.30e-04 | 195 | 31 | 3 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-04 | 195 | 31 | 3 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.34e-04 | 196 | 31 | 3 | 5bb8653af62334ded8aad48b24b64d7b54bc3cd5 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.34e-04 | 196 | 31 | 3 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-04 | 196 | 31 | 3 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 197 | 31 | 3 | 19cf283537c853fa902852e7b8ac1139729a931a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-04 | 197 | 31 | 3 | 179b56147cfb0a5f53c58615f2612b8ef68c8bb8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 197 | 31 | 3 | e14a0e8a893c72356afc5508e3531ae0b23bfe16 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.45e-04 | 198 | 31 | 3 | 5080767ff55326b7d94fca27d398237c4a15c1ed | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 198 | 31 | 3 | 9c0535099750698daac5d6b4d39fb19fecf4ffde | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-04 | 199 | 31 | 3 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.55e-04 | 200 | 31 | 3 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.55e-04 | 200 | 31 | 3 | 5c0135d3cb6f7fa904e9760904dfe5f11c7e9102 | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.55e-04 | 200 | 31 | 3 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.55e-04 | 200 | 31 | 3 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | proximal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.55e-04 | 200 | 31 | 3 | 870ab11343711f64fe6d6a858fc420fe17f1636a | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.55e-04 | 200 | 31 | 3 | 6a5047018b12be3bc4b55a64d42e52e96c624003 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.55e-04 | 200 | 31 | 3 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.55e-04 | 200 | 31 | 3 | 22892afca3666e944102c231b3f10340d8391364 | |
| Computational | Neighborhood of IGFBP1 | 2.06e-06 | 57 | 18 | 4 | CAR_IGFBP1 | |
| Computational | Oxidoreductases. | 5.95e-06 | 22 | 18 | 3 | MODULE_373 | |
| Computational | Genes in the cancer module 514. | 1.18e-04 | 10 | 18 | 2 | MODULE_514 | |
| Drug | 2-NA | 4.18e-13 | 9 | 31 | 5 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 4.18e-13 | 9 | 31 | 5 | CID000440672 | |
| Drug | hexa-2,4-dien-1-ol | 2.62e-12 | 12 | 31 | 5 | CID000008104 | |
| Drug | 2-naphthaldehyde | 4.26e-12 | 13 | 31 | 5 | CID000006201 | |
| Drug | naphthalenemethanol | 6.62e-12 | 14 | 31 | 5 | CID000020908 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 9.92e-12 | 15 | 31 | 5 | CID000440673 | |
| Drug | naphthaldehyde | 1.44e-11 | 16 | 31 | 5 | CID000006195 | |
| Drug | dhmal | 3.87e-10 | 29 | 31 | 5 | CID000151725 | |
| Drug | AC1L1AOQ | 4.64e-10 | 30 | 31 | 5 | CID000001082 | |
| Drug | willardine | 6.54e-10 | 32 | 31 | 5 | CID000005123 | |
| Drug | DOPEG | 1.22e-09 | 36 | 31 | 5 | CID000091528 | |
| Drug | AC1L1J0I | 1.38e-09 | 12 | 31 | 4 | CID000030201 | |
| Drug | 4-Iodopyrazole | 2.29e-09 | 3 | 31 | 3 | DB02721 | |
| Drug | Fomepizole | 9.13e-09 | 4 | 31 | 3 | DB01213 | |
| Drug | 2-butoxyethanol | 2.93e-08 | 24 | 31 | 4 | CID000008133 | |
| Drug | 2,2,2-trichloroethanol | 4.69e-08 | 73 | 31 | 5 | CID000008259 | |
| Drug | Ethanol | 7.97e-08 | 7 | 31 | 3 | DB00898 | |
| Drug | benzyl alcohol | 8.99e-08 | 83 | 31 | 5 | CID000000244 | |
| Drug | walrycin A | 9.84e-08 | 32 | 31 | 4 | ctd:C574123 | |
| Drug | N-heptylformamide | 1.27e-07 | 8 | 31 | 3 | CID000347402 | |
| Drug | Nicotinamide-Adenine-Dinucleotide | 2.48e-07 | 40 | 31 | 4 | DB01907 | |
| Drug | cyclohexanol | 4.41e-07 | 46 | 31 | 4 | CID000007966 | |
| Drug | 3-methylbutanal | 6.48e-07 | 13 | 31 | 3 | CID000011552 | |
| Drug | EGEE | 6.72e-07 | 51 | 31 | 4 | CID000008076 | |
| Drug | chloral hydrate | 8.15e-07 | 129 | 31 | 5 | CID000002707 | |
| Drug | glyceraldehyde | 1.22e-06 | 140 | 31 | 5 | CID000000751 | |
| Drug | phenoxyethanol | 1.26e-06 | 16 | 31 | 3 | CID000031236 | |
| Drug | 1H-pyrazol | 1.27e-06 | 141 | 31 | 5 | CID000001048 | |
| Drug | C x F | 2.18e-06 | 19 | 31 | 3 | CID000013017 | |
| Drug | Peony | 2.56e-06 | 20 | 31 | 3 | CID005483934 | |
| Drug | 4-iodopyrazole | 2.99e-06 | 21 | 31 | 3 | CID000077022 | |
| Drug | 3-hydroxydodecanoate | 2.99e-06 | 21 | 31 | 3 | CID000094216 | |
| Drug | Ethylene Glycol | 2.99e-06 | 21 | 31 | 3 | ctd:D019855 | |
| Drug | Cimetidine | 3.37e-06 | 76 | 31 | 4 | ctd:D002927 | |
| Drug | 4-methylpyrazole | 5.03e-06 | 84 | 31 | 4 | CID000003406 | |
| Drug | 4-methylpiperazine-2,6-dione | 5.82e-06 | 26 | 31 | 3 | CID000124723 | |
| Drug | azoxystrobin | 6.05e-06 | 88 | 31 | 4 | CID003034285 | |
| Drug | fomepizole | 6.54e-06 | 27 | 31 | 3 | ctd:C010238 | |
| Drug | Methanol | 1.00e-05 | 31 | 31 | 3 | ctd:D000432 | |
| Drug | AC1L1G3W | 1.60e-05 | 237 | 31 | 5 | CID000003514 | |
| Drug | 3-hydroxynonanoate | 1.79e-05 | 5 | 31 | 2 | CID000036599 | |
| Drug | 3-hydroxyundecanoate | 1.79e-05 | 5 | 31 | 2 | CID003083221 | |
| Drug | N-1-methylheptylformamide | 1.79e-05 | 5 | 31 | 2 | CID005478865 | |
| Drug | 2-Propanol | 2.02e-05 | 39 | 31 | 3 | ctd:D019840 | |
| Drug | S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2R)-2-[4-(2-methylpropyl)phenyl]propanethioate | 2.35e-05 | 41 | 31 | 3 | CID009854504 | |
| Drug | 1-MCP | 2.35e-05 | 41 | 31 | 3 | CID000151080 | |
| Drug | 3-butylthiolane 1-oxide | 3.75e-05 | 7 | 31 | 2 | CID003363251 | |
| Drug | NADH | 4.23e-05 | 144 | 31 | 4 | DB00157 | |
| Drug | Nile red | 4.29e-05 | 50 | 31 | 3 | CID000065182 | |
| Drug | beta-NADP | 4.49e-05 | 490 | 31 | 6 | CID000000929 | |
| Drug | 5-butyl-2-phenoxyphenol | 5.00e-05 | 8 | 31 | 2 | CID005274975 | |
| Drug | AC1NBLOP | 5.00e-05 | 8 | 31 | 2 | CID004469995 | |
| Drug | 3-keto-LCA | 5.00e-05 | 8 | 31 | 2 | CID000159623 | |
| Drug | disulfiram | 6.07e-05 | 158 | 31 | 4 | CID000003117 | |
| Drug | cysteinylglycine | 6.36e-05 | 57 | 31 | 3 | CID000065270 | |
| Drug | 12-oxododecanoic acid | 6.42e-05 | 9 | 31 | 2 | CID000077563 | |
| Drug | 1-2H | 6.70e-05 | 58 | 31 | 3 | CID000079034 | |
| Drug | UDP-alpha-d-xylopyranose | 7.42e-05 | 60 | 31 | 3 | CID000001165 | |
| Drug | verbenone | 8.02e-05 | 10 | 31 | 2 | CID000029025 | |
| Drug | acetaldehyde | 8.66e-05 | 338 | 31 | 5 | CID000000177 | |
| Drug | allyl alcohol | 9.00e-05 | 64 | 31 | 3 | CID000007858 | |
| Drug | reduced diphosphopyridine nucleotide | 9.15e-05 | 342 | 31 | 5 | CID000000928 | |
| Drug | hex-2-en-1-ol | 9.79e-05 | 11 | 31 | 2 | CID000013577 | |
| Drug | octanol | 9.87e-05 | 66 | 31 | 3 | CID000000957 | |
| Drug | 9-cis-retinol | 1.12e-04 | 357 | 31 | 5 | CID000001071 | |
| Drug | AC1L590V | 1.17e-04 | 12 | 31 | 2 | CID000172417 | |
| Drug | heptadecane | 1.17e-04 | 12 | 31 | 2 | CID000012398 | |
| Drug | 11-cis-retinal | 1.21e-04 | 189 | 31 | 4 | CID000001070 | |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 3904_UP | |
| Drug | 3-hydroxyoctanoate | 1.86e-04 | 15 | 31 | 2 | CID000026613 | |
| Drug | methanol | 2.45e-04 | 227 | 31 | 4 | CID000000887 | |
| Drug | methylthiouracil | 2.71e-04 | 18 | 31 | 2 | CID000667493 | |
| Drug | 3H-DA | 2.71e-04 | 18 | 31 | 2 | CID000026612 | |
| Drug | pentadecane | 3.02e-04 | 19 | 31 | 2 | CID000012391 | |
| Drug | 3-hydroxyvalerate | 3.02e-04 | 19 | 31 | 2 | CID000107802 | |
| Drug | PM H | 3.36e-04 | 20 | 31 | 2 | CID000445008 | |
| Drug | 1-hydroxymethylpyrene | 4.46e-04 | 23 | 31 | 2 | CID000104977 | |
| Drug | diamifen | 4.46e-04 | 23 | 31 | 2 | CID000013482 | |
| Drug | scoparone | 5.28e-04 | 25 | 31 | 2 | CID000008417 | |
| Drug | isopropanol | 6.05e-04 | 122 | 31 | 3 | CID000003776 | |
| Drug | androstenol | 6.17e-04 | 27 | 31 | 2 | CID000101989 | |
| Drug | AC1L18Y7 | 6.17e-04 | 27 | 31 | 2 | CID000000308 | |
| Drug | NADP(H | 6.73e-04 | 527 | 31 | 5 | CID000000930 | |
| Drug | 3-HB | 7.12e-04 | 29 | 31 | 2 | CID000007420 | |
| Drug | glutathione reduced | 7.15e-04 | 534 | 31 | 5 | CID000000745 | |
| Drug | Amphoterin | 8.83e-04 | 139 | 31 | 3 | CID003496889 | |
| Drug | AC1L1CWO | 1.04e-03 | 35 | 31 | 2 | CID000002095 | |
| Drug | M-NR | 1.04e-03 | 35 | 31 | 2 | CID003000480 | |
| Drug | 2-butanol | 1.10e-03 | 36 | 31 | 2 | CID000006568 | |
| Drug | 2gg8 | 1.16e-03 | 37 | 31 | 2 | CID006914647 | |
| Drug | coenzyme 1 | 1.17e-03 | 596 | 31 | 5 | CID000000925 | |
| Drug | rhein | 1.29e-03 | 39 | 31 | 2 | CID000010168 | |
| Drug | AC1NRA3O | 1.36e-03 | 40 | 31 | 2 | CID005287682 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 6.42e-08 | 37 | 31 | 4 | EFO_0007645, EFO_0009458 | |
| Disease | alcohol dependence measurement | 3.27e-07 | 55 | 31 | 4 | EFO_0007835 | |
| Disease | alcohol use disorder measurement | 2.79e-06 | 214 | 31 | 5 | EFO_0009458 | |
| Disease | Alcoholic Intoxication, Chronic | 8.34e-06 | 268 | 31 | 5 | C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 1.07e-05 | 5 | 31 | 2 | 103780 | |
| Disease | Alcohol dependence | 1.07e-05 | 5 | 31 | 2 | cv:C0001973 | |
| Disease | alcohol use disorder (is_implicated_in) | 1.27e-04 | 16 | 31 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 2.22e-04 | 21 | 31 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 2.91e-04 | 24 | 31 | 2 | EFO_0009458, MONDO_0007079 | |
| Disease | parental emotion expression measurmement, conduct disorder | 3.16e-04 | 25 | 31 | 2 | EFO_0004216, EFO_0008342 | |
| Disease | Alcoholic Intoxication | 5.20e-04 | 32 | 31 | 2 | C0001969 | |
| Disease | alcohol dependence | 9.28e-04 | 183 | 31 | 3 | MONDO_0007079 | |
| Disease | Alcohol Use Disorder | 9.83e-04 | 44 | 31 | 2 | C0001956 | |
| Disease | substance-related disorder | 1.37e-03 | 52 | 31 | 2 | MONDO_0002494 | |
| Disease | Mouth Neoplasms | 1.48e-03 | 54 | 31 | 2 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 1.48e-03 | 54 | 31 | 2 | C0153381 | |
| Disease | ecosanoids measurement | 1.53e-03 | 55 | 31 | 2 | EFO_0020044 | |
| Disease | isoleucine measurement | 1.59e-03 | 56 | 31 | 2 | EFO_0009793 | |
| Disease | IGF-1 measurement | 1.63e-03 | 488 | 31 | 4 | EFO_0004627 | |
| Disease | alcohol consumption measurement | 1.64e-03 | 1242 | 31 | 6 | EFO_0007878 | |
| Disease | Alcohol abuse | 2.26e-03 | 67 | 31 | 2 | C0085762 | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.47e-03 | 70 | 31 | 2 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 2.47e-03 | 70 | 31 | 2 | C3241937 | |
| Disease | unipolar depression, alcohol dependence | 3.05e-03 | 78 | 31 | 2 | EFO_0003761, MONDO_0007079 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 4.67e-03 | 97 | 31 | 2 | EFO_0007878, EFO_0009458 | |
| Disease | vitamin D measurement | 5.19e-03 | 336 | 31 | 3 | EFO_0004631 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGHEAAGIVESVGEG | 66 | P07327 | |
| ILGHEGAGIVESIGE | 66 | P28332 | |
| GHEGAGIVESVGEGV | 66 | P11766 | |
| LGHEAAGIVESVGEG | 66 | P00325 | |
| LGHEAAGIVESVGEG | 66 | P00326 | |
| IEGVVEGHIIGTIGH | 206 | O75388 | |
| VEVVGGSDGEGAIGL | 36 | Q8NHZ8 | |
| GGVHIIGGEIGEAFI | 31 | Q8IXT5 | |
| VVFGGGNEGIVDELH | 46 | P51610 | |
| GELGVTVLGGAEHGE | 26 | Q96QZ7 | |
| QDGGGEEEGSGHLVG | 1201 | A9Z1Z3 | |
| EGEVTHVGVGHSGNI | 576 | Q8N1V2 | |
| AVHGGCIGGGVDLVT | 166 | Q13011 | |
| VIVAAGAGGEEGEHV | 11 | Q96EW2 | |
| ITGTGIGGGIIHQHE | 541 | Q9Y223 | |
| NAEGSGGIVGHDEIS | 596 | Q03188 | |
| QDGGEGGVGTVVELG | 26 | Q96AX9 | |
| VAGVGHELGTAGDAG | 116 | Q8NBR6 | |
| GERVKGVGASEGGEE | 1226 | Q8N2Y8 | |
| GASVGTEEDGGGVGH | 11 | A6NHR9 | |
| LNHSGLEEVDGVGGG | 6 | Q8N4K4 | |
| GGGEEVDVHSLGARG | 16 | Q6DKJ4 | |
| TQVVGGHLGDRIGGE | 76 | Q9BYT1 | |
| VAVHPGGDTVAIGGV | 451 | O75083 | |
| EGVSGEEVFAEHGGQ | 116 | P23327 | |
| GIEGVKGAASGVVGE | 1086 | Q5T5C0 | |
| GGAVGAETELVVPGH | 806 | Q9BYN7 | |
| GAQVAGGELLVGEGV | 1196 | Q9BXM0 | |
| GMEGAGVVIAVGEGV | 111 | Q99536 | |
| EGAVVAGEGQGELEG | 241 | Q4V9L6 | |
| QGVGEGGEVGVVGEV | 536 | Q5BKZ1 | |
| GGEVGVVGEVEGVGE | 541 | Q5BKZ1 |